Skip to the page

Data / Drug companies / BluePoint Laboratories

BluePoint Laboratories: 332 products in the FDA NDC directory, labeler code 68001

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

BluePoint Laboratories (labeler code 68001) lists 332 products in the FDA National Drug Code Directory, covering 112 finished drugs by generic name. By type: 298 prescription drugs, 34 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 5, 2026.

The request: Watch BluePoint Laboratories (FDA labeler code 68001): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68001
Products in commercial distribution
332
Packages
476
Finished drugs by generic name
112
Prescription products
298
Over the counter products
34
Flagged as original packager
294 of 294 products that carry the flag
Started marketing in the last 12 months
43
Products with a marketing end date set
11
Earliest marketing start
January 3, 1995
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)31494.6%
Over the counter monograph drugs123.6%
New drug applications (NDA)61.8%

Products by type

TypeProductsShare
Prescription drugs29889.8%
Over the counter drugs3410.2%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Metoprolol succinate1246
Quetiapine1130
Venlafaxine933
Nadolol917
Enoxaparin sodium918
Cyclophosphamide822
Haloperidol decanoate816
Divalproex sodium748
Doxorubicin hydrochloride720
Levetiracetam687
Pemetrexed disodium614
Dasatinib618
Labetalol hydrochloride643
Amlodipine besylate and benazepril hydrochloride612
Leucovorin calcium618
Lisinopril640
Carvedilol435
Diclofenac sodium4109
Bupropion hydrochloride467
Triamterene and hydrochlorothiazide427
Fluorouracil421
Isotretinoin416
Aprepitant47
Fluconazole448
Ramipril419
Metoprolol succinate er tablets48
Etoposide49
Clonidine hydrochloride445
Ziprasidone hydrochloride48
Isosorbide dinitrate418
Duloxetine436
Quinapril410
Imatinib mesylate417
Promethazine hydrochloride349
Lovastatin322
Famotidine3138
Nicotine transdermal system310
Mitomycin314
Fluoxetine342
Nicotine transdermal system patch32
Fluoxetine hydrochloride344
Piperacillin and tazobactam313
Escitalopram334
Nitrofurantoin macrocrystals320
Potassium chloride384
Zonisamide322
Bortezomib326
Glimepiride332
Decitabine318
Nitrofurantion36
Paclitaxel320
Cisplatin311
Zolmitriptan222
Ursodiol228
Fexofenadine hydrochloride265
First aid antibiotic26
Potassium chloride extended-release213
Fulvestrant221
Capecitabine219
Lansoprazole258
Meropenem217
Antipruritic (anti-itch)22
Skin protectant26
Sildenafil253
Antifungal26
Ondansetron252
Abiraterone acetate222
Olopatadine hydrochloride235
Pemetrexed29
Desmopressin acetate227
Diclofenac sodium and misoprostol211
Azacitidine220
Metronidazole268
Fosaprepitant210
Zoledronic acid218
Vancomycin hydrochloride239
Gabapentin291
Duloxetine hydrochloride118
Naloxone hydrochloride140
Atovaquone and proguanil hydrochloride19
Ertapenem sodium111
Palonosetron15
Cetirizine hydrochloride1119
Meclizine hydrochloride chewable14
Bendamustine hydrochloride110
Daptomycin125
Loratadine1125
Methylprednisolone131
Palonosetron hydrochloride111
Irinotecan hydrochloide13
Metaxalone138
Oxaliplatin116
Bacitracin130
Polyethylene glycol 3350167
Lidocaine 4%145
Eribulin mesylate117
Ibuprofen1190
Fosaprepitant dimeglumine112
Guaifenesin1123
Nitrofurantoin (monohydrate/macrocrystals)125

Dosage forms

Dosage formProductsShare
Tablet7923.8%
Tablet, film coated3811.4%
Capsule3410.2%
Injection, powder, lyophilized, for solution329.6%
Injection267.8%
Tablet, extended release257.5%
Injection, solution133.9%
Injection, powder, for solution113.3%
Tablet, delayed release92.7%
Tablet, film coated, extended release92.7%
Patch, extended release61.8%
Ointment61.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Doxorubicin hydrochloride68001-706Injection, suspension, liposomalGeneric drugs (ANDA)October 5, 2026
Doxorubicin hydrochloride68001-707Injection, suspension, liposomalGeneric drugs (ANDA)October 2, 2026
Decitabine68001-713Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 29, 2026
Palonosetron68001-708InjectionGeneric drugs (ANDA)July 15, 2026
Labetalol Hydrochloride68001-702TabletGeneric drugs (ANDA)June 4, 2026
Nicotine Transdermal System Patch Step 168001-699Patch, extended releaseNew drug applications (NDA)May 28, 2026
Nicotine Transdermal System Patch Step 268001-698Patch, extended releaseNew drug applications (NDA)May 28, 2026
Nicotine Transdermal System Patch Step 368001-697Patch, extended releaseNew drug applications (NDA)May 28, 2026
Doxorubicin hydrochloride68001-704Injectable, liposomalGeneric drugs (ANDA)April 2, 2026
Doxorubicin hydrochloride68001-703Injectable, liposomalGeneric drugs (ANDA)April 2, 2026
Paclitaxel68001-705InjectionGeneric drugs (ANDA)April 1, 2026
Teriparatide68001-693InjectionGeneric drugs (ANDA)March 19, 2026
Labetalol Hydrochloride68001-701TabletGeneric drugs (ANDA)March 15, 2026
Labetalol Hydrochloride68001-700TabletGeneric drugs (ANDA)March 15, 2026
Cyclophosphamide68001-696Injection, powder, for solutionGeneric drugs (ANDA)March 15, 2026
Cyclophosphamide68001-695Injection, powder, for solutionGeneric drugs (ANDA)March 15, 2026
Cyclophosphamide68001-694Injection, powder, for solutionGeneric drugs (ANDA)March 15, 2026
Metoprolol Succinate68001-687Tablet, extended releaseGeneric drugs (ANDA)March 1, 2026
Metoprolol Succinate68001-686Tablet, extended releaseGeneric drugs (ANDA)March 1, 2026
Metoprolol Succinate68001-685Tablet, extended releaseGeneric drugs (ANDA)March 1, 2026
Metoprolol Succinate68001-684Tablet, extended releaseGeneric drugs (ANDA)March 1, 2026
Nadolol68001-692TabletGeneric drugs (ANDA)February 25, 2026
Nadolol68001-691TabletGeneric drugs (ANDA)February 25, 2026
Nadolol68001-690TabletGeneric drugs (ANDA)February 25, 2026
Aprepitant68001-668CapsuleGeneric drugs (ANDA)February 10, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.